PER
Click for more information
1.28% 7.9¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-815

  1. raisinsareheresy
    210 Posts.
    lightbulb Created with Sketch. 69
    clock Created with Sketch.
    17/10/21
    23:01
    Post #: 56863969
    Hey @samofdiving

    Great post! Do you mind explaining further what you mean that we don’t need to go through further P2-3 trials to get to market? To my knowledge I thought we needed to run Phase 2B ($27M cost) and Phase 3 before we could commercialise? Would love to understand further if that’s not the case!


    ANP Price at posting: 29.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢ 		Change
0.001(1.28%) 		Mkt cap ! $71.22M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $1.359K 17.36K

Buyers (Bids)

No. Vol. Price($)
3 84867 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 127102 3
View Market Depth
Last trade - 10.20am 23/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.